Potential utility of GB virus type C as a preventive vaccine for HIV-1

  title={Potential utility of GB virus type C as a preventive vaccine for HIV-1},
  author={Omar Bagasra and Alexander U Bagasra and Muhammad Sheraz and Donald Gene Pace},
  journal={Expert Review of Vaccines},
  pages={335 - 347}
Recent flurries of literature on the beneficial effects of GB virus type C (GBV-C), a hepatitis C-related virus, in HIV-1 coinfected individuals have raised the possibility of its potential use as a preventive vaccine in people with a high risk for HIV-1. However, these findings are still controversial, and the mechanisms contributing to the apparent beneficial effects of GBV-C are still unresolved. Researchers debate whether the beneficial effects of coinfection of GBV-C in HIV-1-infected… 

Hepatitis G Virus or GBV-C: A Natural Anti-HIV Interfering Virus

Accumulating evidence indicates that GBV-C effectively overturns HIV’s chances of exploiting the T-cell machinery and leads to enhanced survival rates of HIV-infected subjects.

Use of Flaviviral genetic fragments as a potential prevention strategy for HIV-1 Silencing.

It is hypothesized that a recombinant GBV-C-based vector can be constructed which expresses several beneficial genetic motifs of the Flaviviridae without causing any side effects while stimulating a wide array of beneficial miRNAs that can more efficiently prevent HIV-1 infection.

Review of human pegivirus: Prevalence, transmission, pathogenesis, and clinical implication

The paper aims to summarize the natural history, prevalence and distribution characteristics, and pathogenesis of HPgV-1, and discuss its association with other human viral diseases, and potential use in therapy as a biovaccine or viral vector.

Human pegivirus type 1 infection in Asia—A review of the literature

This review highlights the research conducted thus far and emphasizes the need for additional studies on HPgV‐1 across the Asian continent, including the prevalence and circulating genotypes in all Asian countries with data reported.

Would the interference phenomenon be applied as an alternative option for prophylaxis against COVID-19?

The possibility of the application of interference phenomenon in prophylaxis of the coronavirus disease 2019 is discussed, which has recently been indicated to be exploited for antiviral strategies.

Therapeutic exploitation of viral interference.

SIT could be developed into a biological platform for a new "one drug, multiple bugs" broad-spectrum antiviral treatment approach and for the development of broad spectrum antivirals against emerging viruses a paradigm shift was recently proposed.

A Computational Analysis to Construct a Potential Post-Exposure Therapy against Pox Epidemic Using miRNAs in Silico

There is evidence, using bioinformatics tools, that a new recombinant VACV can be constructed and used as a post-exposure therapy in the case of a zoonotic outbreak or a bioweapon chimera pox created by genetic engineering.

Cellular Targets and Receptor of Sexual Transmission of Zika Virus

The data strongly suggest a potential sexual/horizontal route of transmission for ZikV primarily via infected sperms; most likely ZIKV enters the sperm via the Tyro3 receptor found at the mid-piece of the mature spermatozoa.

Computational identification of mutually homologous Zika virus miRNAs that target microcephaly genes

It is suggested that following infection of fetal neurons ZIKV may modulate the action of various miRNAs, and miR-1304 in particular, resulting in microcephaly.



HIV and GB virus C infections seen from the perspective of the vertically coexposed infant.

It has been found that GBV-C viremia has a tendency to disappear over time in HIV-infected subjects who are followed up longitudinally, and this phenomenon, in turn, is associated with accelerated disease progression.

HIV-GB virus C co-infection: an overview

The question whether GBV-C exerts a protective effect in HIV-infected patients remains to be resolved.

Synthetic peptides of hepatitis G virus (GBV-C/HGV) in the selection of putative peptide inhibitors of the HIV-1 fusion peptide.

The results highlight that the E2(269-286) sequence interacts with the target fusion peptide of HIV-1 and modifies its conformation, which leads to the development of new therapeutic agents for the treatment of AIDS.

Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan.

In Japanese hemophilia patients, coinfection with GBV-C/HGV does not have an adverse effect on the course of HIV infection, and progression to AIDS and to death were slower in patients with GBv-C-HGV coinfections than patients without it, although the differences were not statistically significant.

Effect of coinfection with GB virus C on survival among patients with HIV infection.

GBV-C infection is common in people with HIV infection and is associated with significantly improved survival, and HIV replication was reproducibly inhibited in cultures of peripheral-blood mononuclear cells by GBV- C coinfection.

Peptides Derived from a Distinct Region of GB Virus C Glycoprotein E2 Mediate Strain-Specific HIV-1 Entry Inhibition

Findings reveal a new mechanism of viral interference, suggesting that the envelope protein E2 of GBV-C target directly HIV-1 particles to avoid entry of these virions.

GB virus C infection: is there a clinical relevance for patients infected with the human immunodeficiency virus?

The current knowledge on GB virus C, its role in HIV infection in the HAART era, and the potential mechanisms of its beneficial effect are updated.

Infection with GB virus C and reduced mortality among HIV-infected patients.

BACKGROUND The flavivirus GB virus C (GBV-C, also designated hepatitis G virus) was identified in a search for hepatitis viruses, but no disease is currently known to be associated with it. We

GB Virus Type C: a Beneficial Infection?

Recently, studies found that HIV- positive people who are coinfected with a common, nonpathogenic human flavivirus referred to as GB virus type C (GBV-C) survive significantly longer than do HIV-positive individuals without GBV- C infection.

Effect of synthetic peptides belonging to E2 envelope protein of GB virus C on human immunodeficiency virus type 1 infection.

It is shown how GBV-C E2 domains notably decrease cellular membrane fusion and interfere with the HIV-1 infectivity in a dose-dependent manner, highlighting their potential utility in future anti-HIV-1 therapies.